RxDoctor Payments Data

Curtis Cetrulo, MD

Plastic Surgery · Los Angeles, CANPI 1801084462

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,868 of the $8,766 with a category attached, or 78.3%. TELA Bio, Inc. accounts for 68.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $3,825, more than ten times the $158 reported in 2019.

$8,766in general payments, 2019–2025

Across 74 payments — averaging $118.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$6K
  • Integra Lifesciences Corporation$888
  • RTI Surgical, Inc$506
  • Axogen$361
  • Biocircuit Technologies Inc$261
  • BD$185
  • plus $575 from 6 others
$100,653in research payments, 2019–2025

Across 4 payments — averaging $25,163 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Musculoskeletal Transplant Foundation Inc.$100K
  • Axogen$653

What the payments were for

  • Consulting fees$5006%
  • Travel & lodging$1,39816%
  • Food & beverage$6,86878%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
TELA Bio, Inc.40$5,990
Integra Lifesciences Corporation12$888
RTI Surgical, Inc4$506
Axogen3$361
Biocircuit Technologies Inc3$261
BD2$185
Medical Microinstruments, Inc.4$156
Derma Sciences, Inc.1$136
Mentor Worldwide LLC2$117
Innovation Technologies Inc1$100
Davol Inc.1$41
Smith+Nephew1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,766 in reported general payments places this provider in the 80th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$61,610
Medicare patients
30
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →